Production (Stage)
Biomea Fusion, Inc.
BMEA
$1.48
$0.032.07%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 6.82M | 4.83M | 6.80M | 7.07M | 7.28M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 29.71M | 30.07M | 34.04M | 38.90M | 41.06M |
Operating Income | -29.71M | -30.07M | -34.04M | -38.90M | -41.06M |
Income Before Tax | -29.26M | -29.30M | -32.79M | -37.28M | -39.06M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -29.26M | -29.30M | -32.79M | -37.28M | -39.06M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -29.26M | -29.30M | -32.79M | -37.28M | -39.06M |
EBIT | -29.71M | -30.07M | -34.04M | -38.90M | -41.06M |
EBITDA | -29.24M | -29.61M | -33.60M | -38.48M | -40.64M |
EPS Basic | -0.80 | -0.81 | -0.91 | -1.03 | -1.09 |
Normalized Basic EPS | -0.50 | -0.51 | -0.57 | -0.65 | -0.68 |
EPS Diluted | -0.80 | -0.81 | -0.91 | -1.03 | -1.09 |
Normalized Diluted EPS | -0.50 | -0.51 | -0.57 | -0.65 | -0.68 |
Average Basic Shares Outstanding | 36.63M | 36.27M | 36.22M | 36.04M | 35.89M |
Average Diluted Shares Outstanding | 36.63M | 36.27M | 36.22M | 36.04M | 35.89M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |